Advances in experimental treatment of beta-thalassaemia (Q34232048)

31 July 2017

1 reference

title

Advances in experimental treatment of beta-thalassaemia (English)

1 reference

31 July 2017

Rodgers GP

1

1 reference

31 July 2017

Saunthararajah Y

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Expert Opinion on Investigational Drugs

31 July 2017

published in

1 reference

31 July 2017

volume

10

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

925-934

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

31 July 2017

1 reference

Changing outcome of homozygous alpha-thalassemia: cautious optimism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

Expression of the human .gamma.-globin gene after retroviral transfer to transformed erythroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

Management of thalassaemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

Mechanism of Hb F stimulation by S-stage compounds. In vitro studies with bone marrow cells exposed to 5-azacytidine, Ara-C, or hydroxyurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

Altering gene expression with 5-azacytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

DNA methylation in the human γδβ-globin locus in erythroid and nonerythroid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

The tumorigenicity of 5-azacytidine in the male Fischer rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

5-azacytidine potentiates initiation induced by carcinogens in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

Suppression of intestinal neoplasia by DNA hypomethylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

Mutagenicity of 5-aza-2'-deoxycytidine is mediated by the mammalian DNA methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

Regression of extramedullary haemopoiesis and augmentation of fetal haemoglobin concentration during hydroxyurea therapy in beta thalassaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

The role of recombinant human erythropoietin in the treatment of thalassemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

The therapeutic potential of iron chelators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

Deferiprone: a review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

Hemoglobin switching protocols in thalassemia. Experience with sodium phenylbutyrate and hydroxyurea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

Understanding fetal globin gene expression: a step towards effective HbF reactivation in haemoglobinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

Interaction of heterocellular hereditary persistence of foetal haemoglobin with β thalassaemia and sickle cell anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.925

10.1517/13543784.10.5.925

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference